Company profile: AmbioPharm
1.1 - Company Overview
Company description
- Provider of peptide manufacturing and development services, including GMP and non-GMP custom peptide synthesis via solid phase, solution phase, or hybrid processes. Manufactures active pharmaceutical ingredients and generic peptides, develops research-grade complex peptides, and offers analytical development and validation for HPLC/UPLC, serving pre-clinical, medicinal, and toxicology programs.
Products and services
- GMP Manufacturing: Produces peptides for active pharmaceutical ingredients and generics using solid phase, solution phase, or hybrid processes under cGMP-compliant protocols
- Analytical Development & Validation Services: Architects method-validated HPLC and UPLC methods to monitor process purity and limit impurities for peptide manufacturing
- Custom Peptide Synthesis: Fabricates custom-engineered peptides at various scales utilizing solid phase and solution phase reactors to support pre-clinical in-vitro, medicinal, and toxicology program needs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to AmbioPharm
Modality Solutions
HQ: United States
Website
- Description: Provider of package engineering and controlled-environment logistics solutions for highly regulated industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Modality Solutions company profile →
ImmunXperts
HQ: Belgium
Website
- Description: Provider of in vitro immunology services with a strong focus on immunogenicity and immuno-oncology, helping biopharma companies select their best lead candidates by assessing immune responses in donors and patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ImmunXperts company profile →
Clintrak
HQ: United States
Website
- Description: Provider of clinical-trial printing and labeling solutions, including design and production of single panel and booklet labels for use in clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clintrak company profile →
ZenBio
HQ: United States
Website
- Description: Provider of human cell-based research products and contract research services, including preadipocytes and adipocytes for drug screening and development; cell-based assay development and custom consultations; individualized cell-based or biochemical screening programs; cell characterization and molecular biology services; and ready-to-use visceral preadipocyte and adipocyte media.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ZenBio company profile →
Enavate Sciences
HQ: United States
Website
- Description: Provider of capital and strategic growth support to therapeutic and enabling technology companies, partnering with life sciences companies and their investors to advance and accelerate the development of novel therapies and help companies realize their potential.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enavate Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for AmbioPharm
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to AmbioPharm
2.2 - Growth funds investing in similar companies to AmbioPharm
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for AmbioPharm
4.2 - Public trading comparable groups for AmbioPharm
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →